Header cover image

South Korean Healthcare Undervalued over 20% based on DCF

Results

8

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

8 companies

CLASSYS

Market Cap: ₩3.7t

Provides medical aesthetics devices worldwide.

A214150

₩57,100.00

7D

1.4%

1Y

11.3%

Tomocube

Market Cap: ₩330.0b

Engages in the manufacture and sale of optical devices and medical equipment.

A475960

₩24,900.00

7D

4.6%

1Y

n/a

DuChemBIOLtd

Market Cap: ₩307.5b

Engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea.

A176750

₩10,850.00

7D

3.2%

1Y

-10.3%

UBcare

Market Cap: ₩204.2b

Provides electronic medical record solutions for hospitals, clinics, and pharmacies in South Korea and the United States.

A032620

₩4,025.00

7D

5.1%

1Y

0.4%

Humasis

Market Cap: ₩159.8b

Manufactures and sells pharmaceuticals and medical devices in South Korea and internationally.

A205470

₩1,412.00

7D

-0.6%

1Y

-35.5%

Sewoon Medical

Market Cap: ₩119.1b

Engages in the research and development, manufacture, and sale of medical products in South Korea.

A100700

₩2,750.00

7D

1.7%

1Y

3.8%

Solborn

Market Cap: ₩106.9b

Engages in the manufacturing and sales of medical equipment in South Korea.

A035610

₩4,165.00

7D

-3.4%

1Y

9.9%

Hironic

Market Cap: ₩74.3b

Engages in the manufacture and sale of medical and surgical equipment, and other orthopedic appliances in South Korea and internationally.

A149980

₩5,090.00

7D

0%

1Y

-47.7%